Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Pharmaceuticals
Gilead Sciences is buying a Genentech process research and small-scale biologics manufacturing facility in Oceanside, Calif., where it will produce monoclonal antibodies for clinical studies. Among these is GS 6624, which Gilead acquired in January from Arresto Biosciences and is developing to treat certain cancers and fibrotic diseases. Gilead will offer jobs to about 55 Genentech manufacturing and process development employees. Genentech still owns and operates a commercial manufacturing facility in Oceanside.
This article has been sent to the following recipient: